CCCC
C4 Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
C4 Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
C4 Therapeutics, Inc.
3.36
146 managers report $552.5M of C4 Therapeutics on form 13F for the quarter ended Jun 30 '26. 23 of them hold 80% of it; Morgan Stanley is largest at 7.49%.
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Morgan StanleyMorgan Stanley | $41.4M | 7.49% | −2.26% | |
| 2 | RA Capital ManagementRA Capital Management | $37.4M | 6.76% | 0.00% | |
| 3 | BlackRockBlackRockindex-like | $36.9M | 6.67% | +285.48% | |
| 4 | Squadron Capital ManagementSquadron | $35.5M | 6.42% | +237.78% | |
| 5 | Lynx1 Capital ManagementLynx1 | $34.2M | 6.19% | +4.68% | |
| 6 | Bain Capital Life Sciences InvestorsBain Capital Life Sciences Investors | $33.5M | 6.06% | 0.00% | |
| 7 | JPMorgan ChaseJPMorgan Chase | $20.7M | 3.74% | +47.30% | |
| 8 | Vanguard Capital ManagementVanguardindex-like | $20.6M | 3.73% | +14.39% | |
| 9 | Citadel AdvisorsCitadel | $20.0M | 3.62% | +65.50% | |
| 10 | Goldman Sachs GroupGoldman Sachs | $16.5M | 2.98% | +47.90% | |
| 11 | Wasatch AdvisorsWasatch | $16.5M | 2.98% | +18.94% | |
| 12 | Two Sigma InvestmentsTwo Sigma | $16.2M | 2.93% | +14.30% | |
| 13 | Soleus Capital ManagementSoleus | $15.8M | 2.85% | −11.20% | |
| 14 | Silverarc Capital ManagementSilverarc | $14.2M | 2.56% | +58.60% | |
| 15 | Bank of AmericaBank of America | $12.4M | 2.25% | +12.59% | |
| 16 | Geode Capital ManagementGeodeindex-like | $11.8M | 2.13% | +165.20% | |
| 17 | Ikarian CapitalIkarian Capital | $11.4M | 2.06% | new | |
| 18 | State StreetState Streetindex-like | $9.9M | 1.79% | +452.42% | |
| 19 | Susquehanna International GroupSusquehanna International | $9.5M | 1.72% | +45.56% | |
| 20 | Acadian Asset ManagementAcadian | $8.4M | 1.53% | −4.48% | |
| 21 | Candriam Luxembourg S.C.A.Candriam Luxembourg S.C.A. | $8.4M | 1.52% | new | |
| 22 | D. E. ShawD. E. Shaw | $8.1M | 1.47% | +64.19% | |
| 23 | Patient Square CapitalPatient Square Capital | $7.5M | 1.36% | new | |
| 24 | HighVista StrategiesHighVista Strategies | $6.3M | 1.14% | new | |
| 25 | Renaissance TechnologiesRenaissance Technologies | $5.6M | 1.01% | −51.67% |
Fund move
No thesis.
Linked news
Expected move
Inputsstraddle ±18.9%
spot 3.37exp Nov 20ATM strike 3ATM straddle 0.75IV 113%